We can't find the internet
Attempting to reconnect
16312.1 PFLS-LS
Development of novel bacterial sortase enzymes for site-specific conjugation of payloads to antibodies
Zusammenfassung
Development of novel bacterial sortase enzymes for site-specific conjugation of payloads to antibodies
Weitere Texte
Abstract
Antibody conjugates have recently been proven to be highly potent anti-tumour drugs, exceeding the efficacy of conventional antibodies. There is great commercial interest in|developing site-specific payload conjugation technologies. We have established sortaseenzyme|mediated site-specific toxin conjugation to mAbs with sortase A known in the prior art. We aim to develop novel, patentable sortase variants with improved and altered|specificities for extending the technology and IP base of the commercial partner.
Beteiligte
Ulf Grawunder
Wirtschaftspartner
ulf.grawunder@nbe-therapeutics.com
NBE-Therapeutics GmbH Ulf Grawunder Hochbergerstr. 60C 4057 Basel BS CH
Georg Lipps
Kontaktperson
georg.lipps@fhnw.ch
FHNW Fachhochschule Nordwestschweiz Institut für Chemie und Bioanalytik Georg Lipps Gründenstrasse 40 4132 Muttenz BL CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2014-03-02
- Enddatum
- 2018-01-02
- Bewilligte Gesamtkosten
- CHF 539436.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T490 Biotechnology 100.0%